RP105 protects against myocardial ischemia-reperfusion injury via suppressing TLR4 signaling pathways in rat model

Experimental and Molecular Pathology

Volumn 100, Issue 2, 2016, Pages 281-286

  Li, Xinxin ^a,b   Yang, Jun ^a,b   Yang, Jian ^a,b   Dong, Wusong ^a,b   Li, Song ^a,b   Wu, Hui ^a,b   Li, Li ^a,b  

^a CHINA THREE GORGES UNIVERSITY   (China)

^b Yichang Central People's Hospital   (China)

Author keywords

Inflammatory factors; Myocardial ischemia reperfusion injury; Radioprotective 105 kDa protein (RP105); Toll like receptor 4 (TLR4)

Indexed keywords

ADENOVIRUS VECTOR; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; RADIOPROTECTIVE 105 KDA PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MYD88 PROTEIN, RAT; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; HISTOPATHOLOGY; IN VIVO STUDY; INFLAMMATION; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ADENOVIRIDAE; ANIMAL; CARDIAC MUSCLE; DISEASE MODEL; GENE EXPRESSION; GENE THERAPY; GENE VECTOR; GENETICS; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; INTERLEUKIN-6; MALE; MYELOID DIFFERENTIATION FACTOR 88; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NF-KAPPA B; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84958162754     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2015.12.016     Document Type: Article

References (38)

1. Arslan F., et al. Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targets. Curr. Pharm. Des. 2008, 14:1205-1216.
2. Canbaz S., et al. The effects of intracoronary administration of vitamin E on myocardial ischemia-reperfusion injury during coronary artery surgery. Thorac. Cardiovasc. Surg. 2003, 51:57-61.
3. Castedo E., et al. Ischemia-reperfusion injury during experimental heart transplantation. Evaluation of trimetazidine's cytoprotective effect. Rev. Esp. Cardiol. 2005, 58:941-950.
4. Chen H.H., et al. Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury. Am. J. Physiol. Ren. Physiol. 2009, 297:F1109-F1118.
5. de Vries M.R., et al. Radio protective RP105 protects against vein graft disease and lesion stability via dampening of inflammatory responses. Eur. J. Vasc. Endovasc. Surg. 2015, 49:746.
6. Divanovic S., et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat. Immunol. 2005, 6:571-578.
7. Duraes F.V., et al. IL-12 and TNF-alpha production by dendritic cells stimulated with Schistosoma mansoni schistosomula tegument is TLR4- and MyD88-dependent. Immunol. Lett. 2009, 125:72-77.
8. Feng X.X., He Y. The protective effect of sodium tanshinone II A sulfonate on ischemia-reperfusion injury after thrombolysis of acute myocardial infarction. Chin. J. Biochem. Pharm. 2012, 33:460-462. (in Chinese).
9. Feng Y., et al. Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1311-H1318.
10. Gao Y., et al. TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomed. Pharmacother. 2009, 63:442-450.
11. Ha T., et al. Toll-like receptors: new players in myocardial ischemia/reperfusion injury. Antioxid. Redox Signal. 2011, 15:1875-1893.
12. Hodge D.R., et al. The role of IL-and STAT3 in inflammation and cancer. Eur. J. Cancer 2005, 41:2502-2512.
13. Honda Y., et al. Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis. J. Hepatol. 2007, 47:404-411.
14. Hua F., et al. Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice Is mediated through a phosphoinositide 3-kinase-dependent mechanism. J. Immun. 2007, 178:7317-7324.
15. Karper J., et al. RP105 (cd180) as a TLR-regulator ameliorates atherosclerosis via its role on B-cells. Eur. Heart J. 2014, 34.
16. Kleinbongard P., et al. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol. Ther. 2010, 127:295-314.
17. Koshinuma S., et al. Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury. J. Anesth. 2014, 28:235-241.
18. Lan L., et al. Electroacupuncture exerts anti-inflammatory effects in cerebral ischemia-reperfusion injured rats via suppression of the TLR4/NF-kappaB pathway. Int. J. Mol. Med. 2013, 31:75-80.
19. Li X., et al. The effective method to establish rat models of myocardial ischemia reperfusion. Chin. J. Cardiovasc. Rev. 2007, 5:463-464. (in Chinese).
20. Li Y.W., et al. Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-kappaB p65 signal pathway. Gene 2014, 542:46-51.
21. Lin Z.F., et al. The cardiomyocytes injury efficiency induced by hydrogen peroxide. Prog. Biotechnol. 2004, 81-85. (in Chinese).
22. Louwe M.C., et al. RP105 deficiency aggravates cardiac dysfunction after myocardial infarction in mice. Int. J. Cardiol. 2014, 176:788-793.
23. Luo Y., et al. Altered serum creatine kinase level and cardiac function in ischemia-reperfusion injury during percutaneous coronary intervention. Med. Sci. Monit. 2011, 17:CR474-CR479.
24. Maugeri N., et al. An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes. PLoS ONE 2012, 7.
25. Patel N.S., et al. Endogenous interleukin-enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J. Pharmacol. Exp. Ther. 2005, 312:1170-1178.
26. Pedregosa J.F., et al. TLR2 and TLR4 expression after kidney ischemia and reperfusion injury in mice treated with FTY720. Int. Immunopharmacol. 2011, 11:1311-1318.
27. Rhodus N.L., et al. A comparison of the pro-inflammatory, NF-kappaB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-in different oral fluids from oral lichen planus patients. Clin. Immunol. 2005, 114:278-283.
28. Rui T., et al. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1. Cardiovasc. Res. 2005, 65:719-727.
29. Shibata R., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 2005, 11:1096-1103.
30. Tabari S.Z., et al. Long term evaluation of erythropoietin effects on ischemia-reperfusion injury after coronary artery bypass graft surgery. J. Mazand Univ. Med. Sci. 2012, 22:50-57. (in Persian).
31. Varfolomeev E.E., Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie?. Cell 2004, 116:491-497.
32. Writing Group, M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
33. Wu H., et al. Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-kappaB cytokine pathway. J. Gastrointest. Surg. 2009, 13:983-993.
34. Yang J., et al. Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reperfusion injury. Inflammation 2008, 31:304-312.
35. Yang J., et al. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway. Mol. Cell. Biochem. 2009, 330:39-46.
36. Yang J., et al. Ischemic preconditioning protects against myocardial ischemia-reperfusion injury through inhibiting toll-like receptor 4/NF-κB signaling pathway in rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011, 36:972-978.
37. Zhai C.L., et al. Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway. Acta Pharmacol. Sin. 2012, 33:1477-1487.
38. Zhang W., Guo G. The improvement of establishing an in vivo myocardial ischemic-reperfusion model in rats. Shanxi Med. J. 2009, 38:902-903. (in Chinese).